Simotaxel

DB15384InvestigationalSmall molecule

Simotaxel is under investigation in clinical trial NCT00088647 (Study Evaluating MST-997 in Advanced Malignant Solid Tumors).

Formula / weight: C₄₆H₅₇NO₁₅S · 896.01 g/mol (avg)
Code names: MST-997

Resolves to

Compound

UNIIE1M30YOE59CAS791635-59-1ChEMBLCHEMBL2107372

Structure

InChIKeySLGIWUWTSWJBQE-VLCCYYTCSA-NSMILES

CC(C)OC(=O)N[C@H]([C@@H](O)C(=O)O[C@H]1C[C@@]2(O)[C@@H](OC(=O)C3=CC=CC=C3)[C@@H]3[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(=O)C3CCCC3)C(=C1C)C2(C)C)OC(C)=O)C1=CC=CS1

What you can answer from here — as of February 21, 2021

1Clinical trialPhase, status and sponsor resolved per trial

Which companies are running trials of Simotaxel, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account